T2
Device
Stryker Corporation
Total Payments
$6.8M
Transactions
18,045
Doctors
6,660
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $293,339 | 1,471 | 877 |
| 2023 | $565,701 | 2,234 | 1,374 |
| 2022 | $1.2M | 3,803 | 2,095 |
| 2021 | $942,294 | 3,043 | 1,713 |
| 2020 | $635,158 | 1,341 | 832 |
| 2019 | $1.3M | 2,674 | 1,415 |
| 2018 | $1.1M | 1,887 | 949 |
| 2017 | $822,017 | 1,592 | 889 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.4M | 691 | 35.6% |
| Royalty or License | $1.7M | 33 | 24.8% |
| Unspecified | $1.3M | 207 | 19.5% |
| Food and Beverage | $933,173 | 16,124 | 13.7% |
| Travel and Lodging | $351,567 | 899 | 5.2% |
| Space rental or facility fees (teaching hospital only) | $65,386 | 22 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,392 | 1 | 0.3% |
| Education | $3,804 | 67 | 0.1% |
| Grant | $355.00 | 1 | 0.0% |
Payments by Type
General
$5.5M
17,838 transactions
Research
$1.3M
207 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF TIBIA FRACTURES WITH THE T2 ALPHA TIBIA NAILING SYSTEM | Stryker Corporation | $311,306 | 2 |
| A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF FEMUR FRACTURES WITH THE FEMORAL NAIL PIRIFORMIS FOSSA (PF) OF THE T2 ALPHA FEMUR ANTEGRADE GT/PF NAILING SYSTEM | Stryker Corporation | $155,407 | 1 |
| A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF FEMUR FRACTURES WITH THE FEMORAL NAIL GREATER TROCHANTER (GT) OF THE T2 ALPHA FEMUR ANTEGRADE GT/PF NAILING SYSTEM | Stryker Corporation | $151,578 | 2 |
| A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF FEMORAL FRACTURES WITH THE T2 ALPHA FEMUR RETROGRADE NAILING SYSTEM | Stryker Corporation | $147,839 | 0 |
| A POST-MARKET CLINICAL FOLLOW-UP PMCF OF THE TREATMENT OF TIBIAL FRACTURES WITH THE T2 TIBIAL NAILING SYSTEM | Stryker Corporation | $90,475 | 0 |
| A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF LONG BONE FRACTURES WITH THE T2 KNEE ARTHODESIS NAILING SYSTEM | Stryker Corporation | $51,200 | 0 |
| A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF TIBIA FRACTURES WITH THE T2 ALPHA TIBIA NAILING SYSTEM | Stryker Corporation | $46,910 | 0 |
| METAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANCED STEMS | Stryker Corporation | $43,583 | 0 |
| A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF FEMUR FRACTURES WITH THE FEMORAL NAIL GREATER TROCHANTER GT OF THE T2 ALPHA FEMUR ANTEGRADE GTPF NAILING SYSTEM | Stryker Corporation | $39,780 | 0 |
| MAVRIC MRI USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIDENT II TRITANIUM SYSTEM | Stryker Corporation | $34,243 | 0 |
| A RANDOMIZED CONTROLLED TRIAL COMPARING FREE HAND VERSUS DISTAL TARGETING JIG BASED FOR DISTAL INTERLOCK SCREW PLACEMENT | Stryker Corporation | $31,550 | 0 |
| A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF UPPER AND LOWER EXTREMITY FRACTURES WITH THE T2 KIDS FLEXIBLE NAILING SYSTEM | Stryker Corporation | $27,834 | 0 |
| A RETROSPECTIVE DATA COLLECTIONOF THE TREATMENT OF FEMORAL FRACTURES WITH THE FEMORAL NAIL PIRIFORMIS FOSSA (PF) OF THE T2 ALPHA FEMUR ANTEGRADE GT/PF NAILING SYSTEM | Stryker Corporation | $26,960 | 0 |
| A?RETROSPECTIVE DATA COLLECTION?OF THE TREATMENT OF FEMORAL FRACTURES WITH THE?FEMORAL NAIL GREATER TROCHANTER (GT) OF THE?T2 ALPHA FEMUR ANTEGRADE GT/PF?NAILING SYSTEM? | Stryker Corporation | $24,410 | 0 |
| A POST MARKET CLINICAL FOLLOW UP PMCF OF THE TREATMENT OF TIBIAL FRACTURES WITH THE T2 TIBIAL NAILING SYSTEM | Stryker Corporation | $22,675 | 0 |
| LINKED VS. UNLINKED NAIL PLATE COMBINATIONS FOR COMMINUTED DISTAL FEMUR FRACTURES | Stryker Corporation | $20,000 | 0 |
| A RETROSPECTIVE DATA COLLECTION OF THE INTERNAL FRACTURE FIXATION, STABILIZATION AND SUPPORT OF FRACTURES, AND BONE FIXATION AFTER OSTEOTOMIES WITH THE AXSOS LOCKING PLATE SYSTEM | Stryker Corporation | $17,500 | 0 |
| A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF FEMUR FRACTURES WITH THE T2 FEMORAL NAILING SYSTEM | Stryker Corporation | $17,425 | 0 |
| A POST MARKET CLINIC EVALUATION OF THE TREATMENT OF TIBIA FRACTURES WITH THE T2 ALPHA TIBIA NAILING SYSTEM | Stryker Corporation | $15,275 | 0 |
| TRIDENT II TRITANIUM OUTCOMES STUDY | Stryker Corporation | $14,574 | 0 |
Top Doctors Receiving Payments for T2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Pittsburgh, PA | $1.4M | 236 |
| Dean Maar | — | Indianapolis, IN | $1.4M | 14 |
| , MD | Orthopaedic Surgery | Orlando, FL | $251,580 | 148 |
| , MD | Orthopaedic Trauma | Orlando, FL | $202,607 | 4 |
| , M.D | Orthopaedic Trauma | Indianapolis, IN | $157,366 | 82 |
| , DPM | Foot & Ankle Surgery | Virginia Beach, VA | $124,142 | 37 |
| , M.D | Orthopaedic Surgery | Los Angeles, CA | $89,967 | 103 |
| , M.D | Orthopaedic Surgery | New York, NY | $78,250 | 42 |
| , M.D | Orthopaedic Trauma | Cincinnati, OH | $68,011 | 53 |
| , M.D | Orthopaedic Surgery | Cleveland, OH | $65,955 | 65 |
| , M.D | Orthopaedic Surgery | New York, NY | $57,449 | 44 |
| , MD | Orthopaedic Trauma | Orange, CA | $55,898 | 28 |
| , M.D | Orthopaedic Surgery | Birmingham, AL | $54,502 | 26 |
| , MD | Orthopaedic Trauma | Newark, NJ | $53,894 | 38 |
| , MD | Orthopaedic Trauma | Atlanta, GA | $53,349 | 53 |
| , M.D | Orthopaedic Surgery | Houston, TX | $49,478 | 27 |
| , MD | Orthopaedic Surgery | Melbourne, FL | $45,625 | 40 |
| , MD | Orthopaedic Surgery | Madison, WI | $45,270 | 21 |
| , M.D | Orthopaedic Surgery | New York, NY | $43,758 | 21 |
| , MD | Foot and Ankle Surgery | Washington, DC | $42,791 | 16 |
| , MD | Orthopaedic Trauma | El Paso, TX | $42,403 | 31 |
| , M.D | Orthopaedic Surgery | Peoria, IL | $40,545 | 18 |
| , MD | Orthopaedic Surgery | San Francisco, CA | $39,449 | 56 |
| , DPM | Foot & Ankle Surgery | Dunmore, PA | $34,920 | 17 |
| , MD | Orthopaedic Surgery | Boston, MA | $33,595 | 50 |
Ad
Manufacturing Companies
- Stryker Corporation $6.8M
Product Information
- Type Device
- Total Payments $6.8M
- Total Doctors 6,660
- Transactions 18,045
About T2
T2 is a device associated with $6.8M in payments to 6,660 healthcare providers, recorded across 18,045 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2017 to 2024. In 2024, $293,339 was paid across 1,471 transactions to 877 doctors.
The most common payment nature for T2 is "Consulting Fee" ($2.4M, 35.6% of total).
T2 is associated with 20 research studies, including "A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF TIBIA FRACTURES WITH THE T2 ALPHA TIBIA NAILING SYSTEM" ($311,306).